Before there are any telltale behavioural signs of dementia, a simple test that combines thinking and movement could point to those with a heightened risk of developing Alzheimer’s disease and who are already having visuomotor difficulties, according to new research out of York University.
A study coordinated by the University of Barcelona has described a mechanism that plays a key role in the evolution of Alzheimer’s disease (AD). The activation of the protein Sirtuin 1 in a murine model with familial AD has neuroprotective effects.
Researchers at Tianjin Medical University announced findings that suggest Type 2 diabetes mellitus with mild cognitive impairment accelerated progression to dementia by 2.74 years.
Findings by University of Montana Professor Dr. Lilian Calderón-Garcidueñas, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer’s or Parkinson’s disease.
In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment occurred twice more often in individuals diagnosed with diabetes mellitus type 2.
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.
No front page content has been created yet.